Henlius Added to Hang Seng Composite Index, Eligible for Stock Connect from 7 September 2026

Bulletin Express08-21

Shanghai Henlius Biotech, Inc. (Henlius) disclosed on 21 August 2026 that the company will be included in the Hang Seng Composite Index following the index provider’s quarterly review for the period ended 30 June 2026. The adjustment takes effect on 7 September 2026.

The Hang Seng Composite Index captures roughly the top 95th percentile of total market capitalisation on the Hong Kong Main Board. Henlius’ inclusion therefore positions its H shares to satisfy the criteria for trading under both the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programmes, potentially expanding access for mainland investors.

Management highlighted that index entry signals capital-market recognition of the company’s value and growth prospects, and is expected to widen the shareholder base and improve share liquidity. The board advised shareholders and prospective investors to exercise caution when dealing in the company’s shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1180617623?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-21 20:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180617623","market":"hk","top_or_hot":-1,"title":"Henlius Added to Hang Seng Composite Index, Eligible for Stock Connect from 7 September 2026","media":"Bulletin Express","content":"<p>Shanghai Henlius Biotech, Inc. (Henlius) disclosed on 21 August 2026 that the company will be included in the Hang Seng Composite Index following the index provider’s quarterly review for the period ended 30 June 2026. The adjustment takes effect on 7 September 2026.</p>\n<p>The Hang Seng Composite Index captures roughly the top 95th percentile of total market capitalisation on the Hong Kong Main Board. Henlius’ inclusion therefore positions its H shares to satisfy the criteria for trading under both the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programmes, potentially expanding access for mainland investors.</p>\n<p>Management highlighted that index entry signals capital-market recognition of the company’s value and growth prospects, and is expected to widen the shareholder base and improve share liquidity. The board advised shareholders and prospective investors to exercise caution when dealing in the company’s shares.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Henlius Added to Hang Seng Composite Index, Eligible for Stock Connect from 7 September 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHenlius Added to Hang Seng Composite Index, Eligible for Stock Connect from 7 September 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-21 20:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Henlius Biotech, Inc. (Henlius) disclosed on 21 August 2026 that the company will be included in the Hang Seng Composite Index following the index provider’s quarterly review for the period ended 30 June 2026. The adjustment takes effect on 7 September 2026.</p>\n<p>The Hang Seng Composite Index captures roughly the top 95th percentile of total market capitalisation on the Hong Kong Main Board. Henlius’ inclusion therefore positions its H shares to satisfy the criteria for trading under both the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programmes, potentially expanding access for mainland investors.</p>\n<p>Management highlighted that index entry signals capital-market recognition of the company’s value and growth prospects, and is expected to widen the shareholder base and improve share liquidity. The board advised shareholders and prospective investors to exercise caution when dealing in the company’s shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02696","symbol_name":"复宏汉霖","start_time":0,"source_url":"","article_id":"1180617623","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180617623","pubTimestamp":1787314032,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Henlius Biotech, Inc. (Henlius) disclosed on 21 August 2026 that the company will be included in the Hang Seng Composite Index following the index provider’s quarterly review for the period...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02696":"复宏汉霖"},"translate_title":"复宏汉霖纳入恒生综合指数，自2026年9月7日起符合港股通资格","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02696":1},"content_text":"Shanghai Henlius Biotech, Inc. (Henlius) disclosed on 21 August 2026 that the company will be included in the Hang Seng Composite Index following the index provider’s quarterly review for the period ended 30 June 2026. The adjustment takes effect on 7 September 2026.\nThe Hang Seng Composite Index captures roughly the top 95th percentile of total market capitalisation on the Hong Kong Main Board. Henlius’ inclusion therefore positions its H shares to satisfy the criteria for trading under both the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programmes, potentially expanding access for mainland investors.\nManagement highlighted that index entry signals capital-market recognition of the company’s value and growth prospects, and is expected to widen the shareholder base and improve share liquidity. The board advised shareholders and prospective investors to exercise caution when dealing in the company’s shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1180617623","isCrawlerRequest":true}